Cargando…
A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma
BACKGROUND: Hematogenous metastasis is essential for the progression of advanced hepatocellular carcinoma (HCC) and can occur even after patients receive multidisciplinary therapies, including immunotherapy and hepatectomy; circulating tumor cells (CTCs) are one of the dominant components of the met...
Autores principales: | Huang, Xiu-Yan, Li, Feng, Li, Ting-Ting, Zhang, Jun-Tao, Shi, Xiang-Jun, Huang, Xin-Yu, Zhou, Jian, Tang, Zhao-You, Huang, Zi-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867854/ https://www.ncbi.nlm.nih.gov/pubmed/36681851 http://dx.doi.org/10.1186/s12951-023-01783-9 |
Ejemplares similares
-
Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2023) -
Exosomal proteomics identifies RAB13 as a potential regulator of metastasis for HCC
por: Huang, Xiu-Yan, et al.
Publicado: (2023) -
Research on the Construction of Bispecific-Targeted
Sustained-Release Drug-Delivery Microspheres and Their Function in
Treatment of Hepatocellular Carcinoma
por: Huang, Zi−Li, et al.
Publicado: (2022) -
Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016) -
Multiple Omics Integration Reveals Key Circular RNAs in Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2021)